[An immunoenzymatic technique for the detection of antinuclear antibodies]

H Meriche1, S Meriche-Gadiri, M Ghaffor

  • 1Service d'immunologie, Institut Pasteur, 2, rue du Docteur-Laveran, Alger, Algérie.

Insights

A new immunoenzymatic assay (ANA-EIA) effectively screens for anti-nuclear antibodies (ANA). This test demonstrates high sensitivity and specificity, comparable to the indirect immunofluorescent assay (IFA).

Area of Science:

  • Immunology
  • Clinical Chemistry
  • Diagnostic Assays

Background:

  • Anti-nuclear antibodies (ANA) are critical biomarkers for diagnosing autoimmune rheumatic diseases.
  • The indirect immunofluorescent assay (IFA) is a standard method for ANA detection but can be labor-intensive.
  • There is a need for efficient and reliable ANA screening methods in clinical laboratories.

Purpose of the Study:

  • To develop and evaluate a novel immunoenzymatic assay (ANA-EIA) for detecting anti-nuclear antibodies (ANA).
  • To compare the performance of the ANA-EIA test against the established indirect immunofluorescent assay (IFA).

Main Methods:

  • Development of a simple sandwich-format, heterogeneous-phase immunoenzymatic assay (ANA-EIA).
  • Testing of 292 sera from patients with rheumatic diseases and 40 sera from healthy individuals.
  • Comparative analysis of ANA-EIA results with those obtained from IFA.

Main Results:

  • The ANA-EIA test achieved a sensitivity of 97% and a specificity of 96%.
  • Global concordance between ANA-EIA and IFA was 96.6%, with a discordance rate of 3.4%.
  • Excellent agreement was observed for homogeneous, speckled, and nucleolar ANA patterns; cytoplasmic patterns require further investigation.

Conclusions:

  • The ANA-EIA test is a highly sensitive and specific method for ANA screening.
  • Its ease of use and analytical performance make it suitable for routine application in immunopathology laboratories.
  • ANA-EIA offers a reliable alternative to IFA for ANA detection in clinical settings.

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
Immunogold Electron Microscopy01:20

Immunogold Electron Microscopy

Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.